Frg1-KO Mouse
Common Name
Frg1-KO
제품 ID
S-KO-02117
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-14300-Frg1-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Frg1-KO Mouse (카탈로그 번호 S-KO-02117)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Frg1-KO
품종 계통계통 ID
KOCMP-14300-Frg1-B6J-VB
유전자명
제품 ID
S-KO-02117
유전자 별칭
--
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 8
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000033999
NCBI 전사체 ID
NM_013522
타겟 영역
Exon 3~4
유효 영역 크기
~1.9 kb
유전자 연구 개요
FRG1, short for FSHD region gene 1, is the primary candidate gene for Fascioscapulohumeral Muscular Dystrophy (FSHD). It has been implicated in multiple physiological processes. Mechanistically, it may play a role in RNA biogenesis, influencing pathways like mRNA surveillance, RNA transport, and spliceosome machinery [1]. It is also associated with processes such as muscle development, vasculogenesis, angiogenesis, and tumorigenesis [1,2,3,4,5,6,7,8]. Genetic models, like those in Xenopus laevis and mouse myoblasts, have been valuable in studying its functions [7,9].
In terms of specific findings, in Xenopus laevis, frg1 is expressed in and essential for tadpole musculature development. Disrupting its expression led to myotome organization and growth defects, while overexpression caused abnormal muscle formation, suggesting its crucial role in proper muscle development [7]. In mouse myoblasts overexpressing FRG1, decreased proliferation was observed, which may contribute to the pathology of FSHD [9]. In cancer studies, reduced FRG1 expression promoted angiogenesis via the FGF2-mediated ERK/AKT pathway in breast cancer [2], and in prostate cancer, it affected cell migration and invasion, likely through p38 MAPK activation [4]. FRG1 also seems to play a role in DNA repair in breast cancer, with low expression associated with reduced DNA repair capabilities and a higher frequency of TP53 mutation [3].
In conclusion, FRG1 is vital for muscle development and has significant implications in angiogenesis, tumorigenesis, and DNA repair. Studies using genetic models, especially in muscle-related and cancer-related disease areas, have revealed its multifaceted functions. Understanding FRG1 can potentially provide insights into the pathophysiology of FSHD and cancer, offering new directions for therapeutic strategies.
References:
1. Palo, Ananya, Patel, Saket Awadhesbhai, Sahoo, Bibekananda, Chowdary, Tirumala Kumar, Dixit, Manjusha. 2022. FRG1 is a direct transcriptional regulator of nonsense-mediated mRNA decay genes. In Genomics, 115, 110539. doi:10.1016/j.ygeno.2022.110539. https://pubmed.ncbi.nlm.nih.gov/36521634/
2. Mukherjee, Bratati, Brahma, Pratush, Mohapatra, Talina, Chawla, Saurabh, Dixit, Manjusha. 2023. Reduced FRG1 expression promotes angiogenesis via activation of the FGF2-mediated ERK/AKT pathway. In FEBS open bio, 13, 804-817. doi:10.1002/2211-5463.13582. https://pubmed.ncbi.nlm.nih.gov/36815234/
3. Shubhanjali, Shubhanjali, Mohapatra, Talina, Khan, Rehan, Dixit, Manjusha. 2024. Unveiling FRG1's DNA repair role in breast cancer. In Scientific reports, 14, 19371. doi:10.1038/s41598-024-70368-9. https://pubmed.ncbi.nlm.nih.gov/39169067/
4. Tiwari, Ankit, Mukherjee, Bratati, Hassan, Md Khurshidul, Jaiswal, Archita Mohanty, Dixit, Manjusha. 2019. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion. In BMC cancer, 19, 346. doi:10.1186/s12885-019-5509-4. https://pubmed.ncbi.nlm.nih.gov/30975102/
5. Mukherjee, Bratati, Tiwari, Ankit, Palo, Ananya, Samantara, Subrat, Dixit, Manjusha. 2022. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF. In Cell death discovery, 8, 442. doi:10.1038/s41420-022-01240-w. https://pubmed.ncbi.nlm.nih.gov/36329016/
6. DeSimone, Alec M, Pakula, Anna, Lek, Angela, Emerson, Charles P. 2017. Facioscapulohumeral Muscular Dystrophy. In Comprehensive Physiology, 7, 1229-1279. doi:10.1002/cphy.c160039. https://pubmed.ncbi.nlm.nih.gov/28915324/
7. Hanel, Meredith L, Wuebbles, Ryan D, Jones, Peter L. . Muscular dystrophy candidate gene FRG1 is critical for muscle development. In Developmental dynamics : an official publication of the American Association of Anatomists, 238, 1502-12. doi:10.1002/dvdy.21830. https://pubmed.ncbi.nlm.nih.gov/19097195/
8. Hansda, Arman Kunwar, Tiwari, Ankit, Dixit, Manjusha. . Current status and future prospect of FSHD region gene 1. In Journal of biosciences, 42, 345-353. doi:. https://pubmed.ncbi.nlm.nih.gov/28569257/
9. Chen, Steven C, Frett, Ellie, Marx, Joseph, Kyba, Michael, Kennedy, Brian K. 2011. Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1. In PloS one, 6, e19780. doi:10.1371/journal.pone.0019780. https://pubmed.ncbi.nlm.nih.gov/21603621/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
